Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 679259, 6 pages
http://dx.doi.org/10.1155/2014/679259
Research Article

Protective Effect of Agaricus brasiliensis on STZ-Induced Diabetic Neuropathic Pain in Rats

1Department of Orthopedics, Chinese Orthopedics and Traumatology Research Institute, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, China
2School of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China
3School of Basic Medicine, Fujian Medical University, Fuzhou 350108, China
4Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China

Received 16 October 2013; Accepted 12 November 2013; Published 12 January 2014

Academic Editor: Bo Cui

Copyright © 2014 Weifeng Ji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. McKeage, “Treatment options for the management of diabetic painful neuropathy: best current evidence,” Current Opinion in Neurology, vol. 20, no. 5, pp. 553–557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. P. Kellogg, H. T. Cheng, and R. Pop-Busui, “Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy,” Current Drug Targets, vol. 9, no. 1, pp. 68–76, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Chong and J. Hester, “Diabetic painful neuropathy: current and future treatment options,” Drugs, vol. 67, no. 4, pp. 569–585, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. B. O'Connor, “Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy,” PharmacoEconomics, vol. 27, no. 2, pp. 95–112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Firenzuoli, L. Gori, and G. Lombardo, “The medicinal mushroom Agaricus blazei murrill: review of literature and pharmaco-toxicological problems,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 3–15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. A. Al-Fatimi, W.-D. Jülich, R. Jansen, and U. Lindequist, “Bioactive components of the traditionally used mushroom Podaxis pistillaris,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 1, pp. 87–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. P. Wasser and A. L. Weis, “Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective,” Critical Reviews in Immunology, vol. 19, no. 1, pp. 65–96, 1999. View at Google Scholar · View at Scopus
  8. C. H. Hsu, Y. L. Liao, S. C. Lin, K. Hwang, and P. Chou, “The mushroom Agaricus brasiliensis in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial,” Journal of Alternative and Complementary Medicine, vol. 13, no. 1, pp. 97–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Chen, H. J. Shao, and Y. B. Su, “Coimmunization of Agaricus brasiliensis extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses,” International Immunopharmacology, vol. 4, no. 3, pp. 403–409, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Han, J. Yuan, Y. Wang, and L. Li, “Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium,” Journal of Trace Elements in Medicine and Biology, vol. 20, no. 3, pp. 191–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. L. O. Randall and J. Selitto, “A method for measurement of analgesic activity of inflamed tissue,” Archives Internationales de Pharmacodynamie et de Thérapie, vol. 111, no. 4, pp. 209–219, 1957. View at Google Scholar
  12. S. R. Chaplan, F. W. Bach, J. W. Pogrel, J. M. Chung, and T. L. Yaksh, “Quantitative assessment of tactile allodynia in the rat paw,” Journal of Neuroscience Methods, vol. 53, no. 1, pp. 55–63, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Necker and R. F. Hellon, “Noxious thermal input from the rat tail: modulation by descending inhibitory influences,” Pain, vol. 4, no. 3, pp. 231–242, 1978. View at Publisher · View at Google Scholar · View at Scopus
  14. H. P. Misra and I. Fridovich, “The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase,” Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170–3175, 1972. View at Google Scholar · View at Scopus
  15. T. F. Slater and B. C. Sawyer, “The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used,” Biochemical Journal, vol. 123, no. 5, pp. 805–814, 1971. View at Google Scholar · View at Scopus
  16. K. M. Miranda, M. G. Espey, and D. A. Wink, “A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite,” Nitric Oxide, vol. 5, no. 1, pp. 62–71, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. S. L. Bonting, “Membrane and ion transport,” in Presence of Enzyme Systems in Mammalian Tissues, E. E. Bilter, Ed., vol. 2, pp. 257–263, Wiley Interscience, London, UK, 1970. View at Google Scholar
  18. N. A. Calcutt and S. R. Chaplan, “Spinal pharmacology of tactile allodynia in diabetic rats,” British Journal of Pharmacology, vol. 122, no. 7, pp. 1478–1482, 1997. View at Google Scholar · View at Scopus
  19. N. Rakieten, M. L. Rakieten, and M. R. Nadkarni, “Studies on the diabetogenic action of streptozotocin (NSC-37917),” Cancer Chemotherapy Reports, vol. 29, pp. 91–98, 1963. View at Google Scholar · View at Scopus
  20. C. Courteix, A. Eschalier, and J. Lavarenne, “Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain,” Pain, vol. 53, no. 1, pp. 81–88, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. C. H. Hsu, Y. L. Liao, S. C. Lin, K. Hwang, and P. Chou, “The mushroom Agaricus brasiliensis in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial,” Journal of Alternative and Complementary Medicine, vol. 13, no. 1, pp. 97–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Meeus and J. Nijs, “Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome,” Clinical Rheumatology, vol. 26, no. 4, pp. 465–473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. T. Velazques, H. Mohammad, and S. M. Swetzer, “Protein kinase in pain: involvement of multiple isoforms,” Pharmacological Research, vol. 55, no. 6, pp. 578–589, 2007. View at Publisher · View at Google Scholar
  24. M. Friederich, P. Hansell, and F. Palm, “Diabetes, oxidative stress, nitric oxide and mitochondria function,” Current Diabetes Reviews, vol. 5, no. 2, pp. 120–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Ozkul, M. Ayhan, C. Yenisey, A. Akyol, E. Guney, and F. A. Ergin, “The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain,” Neuroendocrinology Letters, vol. 31, no. 2, pp. 261–264, 2010. View at Google Scholar · View at Scopus
  26. S. Y. Kim, J. H. Lee, E. S. Yang, I. S. Kil, and J. Park, “Human sensitive to apoptosis gene protein inhibits peroxynitrite-induced DNA damage,” Biochemical and Biophysical Research Communications, vol. 301, no. 3, pp. 671–674, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. R. Dasu, S. Ramirez, and R. R. Isseroff, “Toll-like receptors and diabetes: a therapeutic perspective,” Clinical Science, vol. 122, no. 5, pp. 203–214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. L. R. Watkins and S. F. Maier, “Glia: a novel drug discovery target for clinical pain,” Nature Reviews Drug Discovery, vol. 2, no. 12, pp. 973–985, 2003. View at Google Scholar · View at Scopus
  29. Y. Wang, A. M. Schmeichel, H. Iida, J. D. Schmelzer, and P. A. Low, “Enhanced inflammatory response via activation of NF-κB in acute experimental diabetic neuropathy subjected to ischemia-reperfusion injury,” Journal of the Neurological Sciences, vol. 247, no. 1, pp. 47–52, 2006. View at Publisher · View at Google Scholar · View at Scopus